Irritable bowel syndrome monitoring: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Irritable bowel syndrome}} | {{Irritable bowel syndrome}} | ||
{{CMG}} | {{CMG}} {{AE}} {{Cherry}} | ||
==Overview== | ==Overview== | ||
Response to therapy in IBS patients may be monitored by using questionnaires or scales such as Patient Health Questionnaire (PHQ)-15, [https://static-content.springer.com/esm/art%3A10.1186%2F1471-230X-8-30/MediaObjects/12876_2008_263_MOESM2_ESM.pdf Birmingham IBS Symptom Questionnaire], IBS Symptom Severity Scale and the Gastrointestinal Symptom Rating Scale. These are both objective and subjective evaluations and help guide further management of patients. | Response to [[therapy]] in [[Irritable bowel syndrome|IBS]] [[Patient|patients]] may be monitored by using [[Questionnaire|questionnaires]] or [[Scale (social sciences)|scales]] such as Patient Health Questionnaire (PHQ)-15, [https://static-content.springer.com/esm/art%3A10.1186%2F1471-230X-8-30/MediaObjects/12876_2008_263_MOESM2_ESM.pdf Birmingham IBS Symptom Questionnaire], IBS Symptom Severity Scale and the Gastrointestinal Symptom Rating Scale. These are both objective and subjective evaluations and help guide further management of [[Patient|patients]]. | ||
===Monitoring === | ===Monitoring === | ||
IBS may be monitored to gauge response to therapy : | Irritable bowel syndrome ([[Irritable bowel syndrome|IBS]]) may be monitored to gauge response to therapy : | ||
* Patient Health Questionnaire (PHQ)-15<ref name="pmid20955447">{{cite journal| author=Spiegel BM, Bolus R, Agarwal N, Sayuk G, Harris LA, Lucak S et al.| title=Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials. | journal=Aliment Pharmacol Ther | year= 2010 | volume= 32 | issue= 10 | pages= 1275-91 | pmid=20955447 | doi=10.1111/j.1365-2036.2010.04464.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20955447 }} </ref> | * Patient Health Questionnaire (PHQ)-15<ref name="pmid20955447">{{cite journal| author=Spiegel BM, Bolus R, Agarwal N, Sayuk G, Harris LA, Lucak S et al.| title=Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials. | journal=Aliment Pharmacol Ther | year= 2010 | volume= 32 | issue= 10 | pages= 1275-91 | pmid=20955447 | doi=10.1111/j.1365-2036.2010.04464.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20955447 }} </ref> | ||
* [https://static-content.springer.com/esm/art%3A10.1186%2F1471-230X-8-30/MediaObjects/12876_2008_263_MOESM2_ESM.pdf Birmingham IBS Symptom Questionnaire] <ref name="pmid18651941">{{cite journal| author=Roalfe AK, Roberts LM, Wilson S| title=Evaluation of the Birmingham IBS symptom questionnaire. | journal=BMC Gastroenterol | year= 2008 | volume= 8 | issue= | pages= 30 | pmid=18651941 | doi=10.1186/1471-230X-8-30 | pmc=2496907 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18651941 }} </ref><ref name="pmid25574104">{{cite journal| author=Jasper F, Egloff B, Roalfe A, Witthöft M| title=Latent structure of irritable bowel syndrome symptom severity. | journal=World J Gastroenterol | year= 2015 | volume= 21 | issue= 1 | pages= 292-300 | pmid=25574104 | doi=10.3748/wjg.v21.i1.292 | pmc=4284348 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25574104 }} </ref> | * [https://static-content.springer.com/esm/art%3A10.1186%2F1471-230X-8-30/MediaObjects/12876_2008_263_MOESM2_ESM.pdf Birmingham IBS Symptom Questionnaire] <ref name="pmid18651941">{{cite journal| author=Roalfe AK, Roberts LM, Wilson S| title=Evaluation of the Birmingham IBS symptom questionnaire. | journal=BMC Gastroenterol | year= 2008 | volume= 8 | issue= | pages= 30 | pmid=18651941 | doi=10.1186/1471-230X-8-30 | pmc=2496907 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18651941 }} </ref><ref name="pmid25574104">{{cite journal| author=Jasper F, Egloff B, Roalfe A, Witthöft M| title=Latent structure of irritable bowel syndrome symptom severity. | journal=World J Gastroenterol | year= 2015 | volume= 21 | issue= 1 | pages= 292-300 | pmid=25574104 | doi=10.3748/wjg.v21.i1.292 | pmc=4284348 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25574104 }} </ref> | ||
* IBS Symptom Severity Scale.<ref name="pmid9146781">{{cite journal| author=Francis CY, Morris J, Whorwell PJ| title=The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. | journal=Aliment Pharmacol Ther | year= 1997 | volume= 11 | issue= 2 | pages= 395-402 | pmid=9146781 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9146781 }} </ref> | * IBS Symptom Severity Scale.<ref name="pmid9146781">{{cite journal| author=Francis CY, Morris J, Whorwell PJ| title=The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. | journal=Aliment Pharmacol Ther | year= 1997 | volume= 11 | issue= 2 | pages= 395-402 | pmid=9146781 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9146781 }} </ref> | ||
** <175, mild IBS | ** <175, mild [[Irritable bowel syndrome|IBS]] | ||
** 175−300, moderate IBS | ** 175−300, moderate [[Irritable bowel syndrome|IBS]] | ||
** >300 severe IBS | ** >300 severe [[Irritable bowel syndrome|IBS]] | ||
** An increase or decrease by at least 50 points is significant. | ** An increase or decrease by at least 50 points is significant. | ||
* The Gastrointestinal Symptom Rating Scale has been modified for use in patients with IBS (GSRS-IBS) <ref name="pmid14531531">{{cite journal| author=Wiklund IK, Fullerton S, Hawkey CJ, Jones RH, Longstreth GF, Mayer EA et al.| title=An irritable bowel syndrome-specific symptom questionnaire: development and validation. | journal=Scand J Gastroenterol | year= 2003 | volume= 38 | issue= 9 | pages= 947-54 | pmid=14531531 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14531531 }} </ref> | * The Gastrointestinal Symptom Rating Scale has been modified for use in patients with [[Irritable bowel syndrome|IBS]] (GSRS-IBS) <ref name="pmid14531531">{{cite journal| author=Wiklund IK, Fullerton S, Hawkey CJ, Jones RH, Longstreth GF, Mayer EA et al.| title=An irritable bowel syndrome-specific symptom questionnaire: development and validation. | journal=Scand J Gastroenterol | year= 2003 | volume= 38 | issue= 9 | pages= 947-54 | pmid=14531531 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14531531 }} </ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Latest revision as of 22:26, 29 July 2020
|
Irritable bowel syndrome Microchapters |
|
Differentiating Irritable bowel syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Irritable bowel syndrome monitoring On the Web |
|
American Roentgen Ray Society Images of Irritable bowel syndrome monitoring |
|
Risk calculators and risk factors for Irritable bowel syndrome monitoring |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]
Overview
Response to therapy in IBS patients may be monitored by using questionnaires or scales such as Patient Health Questionnaire (PHQ)-15, Birmingham IBS Symptom Questionnaire, IBS Symptom Severity Scale and the Gastrointestinal Symptom Rating Scale. These are both objective and subjective evaluations and help guide further management of patients.
Monitoring
Irritable bowel syndrome (IBS) may be monitored to gauge response to therapy :
- Patient Health Questionnaire (PHQ)-15[1]
- Birmingham IBS Symptom Questionnaire [2][3]
- IBS Symptom Severity Scale.[4]
- The Gastrointestinal Symptom Rating Scale has been modified for use in patients with IBS (GSRS-IBS) [5]
References
- ↑ Spiegel BM, Bolus R, Agarwal N, Sayuk G, Harris LA, Lucak S; et al. (2010). "Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials". Aliment Pharmacol Ther. 32 (10): 1275–91. doi:10.1111/j.1365-2036.2010.04464.x. PMID 20955447.
- ↑ Roalfe AK, Roberts LM, Wilson S (2008). "Evaluation of the Birmingham IBS symptom questionnaire". BMC Gastroenterol. 8: 30. doi:10.1186/1471-230X-8-30. PMC 2496907. PMID 18651941.
- ↑ Jasper F, Egloff B, Roalfe A, Witthöft M (2015). "Latent structure of irritable bowel syndrome symptom severity". World J Gastroenterol. 21 (1): 292–300. doi:10.3748/wjg.v21.i1.292. PMC 4284348. PMID 25574104.
- ↑ Francis CY, Morris J, Whorwell PJ (1997). "The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress". Aliment Pharmacol Ther. 11 (2): 395–402. PMID 9146781.
- ↑ Wiklund IK, Fullerton S, Hawkey CJ, Jones RH, Longstreth GF, Mayer EA; et al. (2003). "An irritable bowel syndrome-specific symptom questionnaire: development and validation". Scand J Gastroenterol. 38 (9): 947–54. PMID 14531531.